NL8104832A - Nieuwe beta-galactosidase-remmer. - Google Patents

Nieuwe beta-galactosidase-remmer. Download PDF

Info

Publication number
NL8104832A
NL8104832A NL8104832A NL8104832A NL8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A NL 8104832 A NL8104832 A NL 8104832A
Authority
NL
Netherlands
Prior art keywords
galactosidase
activity
pharmaceutically acceptable
enzyme
methanol
Prior art date
Application number
NL8104832A
Other languages
English (en)
Dutch (nl)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NL8104832A publication Critical patent/NL8104832A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL8104832A 1980-10-27 1981-10-26 Nieuwe beta-galactosidase-remmer. NL8104832A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15092780 1980-10-27
JP55150927A JPS5774090A (en) 1980-10-27 1980-10-27 Novel beta-galactosidase inhibitor, gt-2558, its derivative, and production

Publications (1)

Publication Number Publication Date
NL8104832A true NL8104832A (nl) 1982-05-17

Family

ID=15507444

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8104832A NL8104832A (nl) 1980-10-27 1981-10-26 Nieuwe beta-galactosidase-remmer.

Country Status (7)

Country Link
US (1) US4497797A (fr)
JP (1) JPS5774090A (fr)
DE (1) DE3142400A1 (fr)
FR (1) FR2492664A1 (fr)
GB (1) GB2086394B (fr)
NL (1) NL8104832A (fr)
NZ (1) NZ198680A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0684377B1 (fr) * 1986-04-17 1994-10-26 Kyowa Hakko Kogyo Kk
EP0313846B1 (fr) * 1987-10-29 1994-05-04 American Cyanamid Company Méthode de contrôle de maladies chroniques respiratoires, et d entérites nérotiques chez les oiseaux
US5179023A (en) * 1989-03-24 1993-01-12 Research Corporation Technologies, Inc. Recombinant α-galactosidase a therapy for Fabry disease
AU702122B2 (en) * 1994-10-25 1999-02-11 Merck & Co., Inc. Microbial synthesis of HIV protease inhibitors
US6210666B1 (en) 1997-10-21 2001-04-03 Orphan Medical, Inc. Truncated α-galactosidase A to treat fabry disease
CN103502458B (zh) 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
CN106687596A (zh) * 2014-02-17 2017-05-17 葛兰素史密斯克莱知识产权发展有限公司 微生物学方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3160560A (en) * 1957-08-23 1964-12-08 Upjohn Co Streptolydigin and production thereof
JPS5134916B2 (fr) * 1974-03-06 1976-09-29
US3991183A (en) * 1975-05-01 1976-11-09 Pfizer Inc. Antibiotic produced by a species of micromonospora

Also Published As

Publication number Publication date
NZ198680A (en) 1985-04-30
GB2086394A (en) 1982-05-12
GB2086394B (en) 1984-03-07
JPS5774090A (en) 1982-05-10
US4497797A (en) 1985-02-05
FR2492664A1 (fr) 1982-04-30
DE3142400A1 (de) 1982-11-25
FR2492664B1 (fr) 1985-04-19

Similar Documents

Publication Publication Date Title
US4254256A (en) Amino sugar compound
US4460765A (en) Enzyme inhibitor produced by cultivation of streptomyces microorganisms
SE468482B (sv) Framstaellning av monakolin k
EP0182315A2 (fr) Antibiotique NK84-0218, compositions pharmaceutiques le contenant et procédé pour sa production
CA1153966A (fr) Ebelactone, substance ayant une action physiologique et methode de production
NL8104832A (nl) Nieuwe beta-galactosidase-remmer.
AU7677600A (en) Process for the preparation of mycophenolic acid and derivatives thereof
EP0019302A1 (fr) Composés tétracycliques, procédés pour leur préparation, leur utilisation et compositions pharmaceutiques
DE2109854B2 (de) 7beta-(D-5-Amino-5-carboxy valeramido)-3-(carbamoyloxymethyl>7-methoxy-3-cephem-4-carbonsäure und deren Salze, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arzneimittel
CH618606A5 (fr)
EP0317292B1 (fr) Antibiotiques du groupe muréidomycine, leur préparation et leur emploi
US5039663A (en) Antibiotics called "mureidomycins A, B, C, and D" and their therapeutic use
US4197292A (en) Novel amylase inhibitors
US4011140A (en) Process for producing antitumor compound
US3974035A (en) Process for preparing a cephamycin type antibiotic substance
JP2592468B2 (ja) 新規抗生物質ベナノマイシンaおよびbならびにその製造法
JPS5823077B2 (ja) 抗生物質am−3603およびその製造方法
US3825660A (en) Antibiotic no.156 and process for producing the same
US4661352A (en) WS 7739 substances, their preparation and pharmaceutical composition containing the same
JPH0578322A (ja) 新規抗生物質sf2738物質及びその製造法並びに制癌剤
US4242327A (en) Antibiotic SF-2052 substance and production and use thereof
US4803074A (en) FR-900848 substance and preparation thereof
CA1077421A (fr) Antibiotique sf-1540 produit par un streptomyces
US3857756A (en) Process for production of antibiotic
DE69300658T2 (de) Anthracyclin Analogon, Verbindung UCEG.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed